151 related articles for article (PubMed ID: 33901809)
1. Correlation of Tim-3 expression with chemokine levels for predicting the prognosis of patients with glioblastoma.
Zhu Z; Zhang X; Yu Z; Zhou Y; Zhu S; Zhang YH; Lin XP; Mou Y; Zhang J
J Neuroimmunol; 2021 Jun; 355():577575. PubMed ID: 33901809
[TBL] [Abstract][Full Text] [Related]
2. BACH1 as a potential target for immunotherapy in glioblastomas.
Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment.
Li C; Deng H; Zhou Y; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
Life Sci; 2020 Nov; 261():118486. PubMed ID: 32976881
[TBL] [Abstract][Full Text] [Related]
4. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma.
Gao W; Li Y; Zhang T; Lu J; Pan J; Qi Q; Dong S; Chen X; Su Z; Li J
J Inflamm Res; 2022; 15():2731-2743. PubMed ID: 35509325
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.
Huang G; Hou X; Li X; Yu Y; Ge X; Gan H
Medicine (Baltimore); 2024 Feb; 103(7):e35828. PubMed ID: 38363895
[TBL] [Abstract][Full Text] [Related]
12. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
13. Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas.
Li J; Liu X; Duan Y; Liu Y; Wang H; Lian S; Zhuang G; Fan Y
Med Sci Monit; 2017 Jul; 23():3593-3602. PubMed ID: 28736431
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
15. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.
Deng L; Ren J; Li B; Wang Y; Jiang N; Wang Y; Cui H
BMC Genomics; 2023 Dec; 24(1):746. PubMed ID: 38057698
[TBL] [Abstract][Full Text] [Related]
17. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of DNA methylation-driven gene PCDHB4 as a novel tumor suppressor for glioblastoma diagnosis and prognosis.
Huang H; Xie Y; Chen X; Zhang D; Zhang X; Deng Y; Huang Z; Bi H; Hu X; Yan X; Liang H; Lv Z; Sun X; Zhang M; Hu D; Hu F
Mol Carcinog; 2023 Dec; 62(12):1832-1845. PubMed ID: 37560880
[TBL] [Abstract][Full Text] [Related]
19. In search of druggable targets for GBM amino acid metabolism.
Panosyan EH; Lin HJ; Koster J; Lasky JL
BMC Cancer; 2017 Feb; 17(1):162. PubMed ID: 28245795
[TBL] [Abstract][Full Text] [Related]
20. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
Cui G; Xiao Y
Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
